UBS Maintains Buy on Eastman Chemical, Lowers Price Target to $77

Benzinga Newsdesk www.benzinga.com Negative 69.6%

Neg 69.6% Neu 0% Pos 0%

UBS analyst Joshua Spector maintains Eastman Chemical (NYSE:EMN) with a Buy and lowers the price target from $92 to $77.